{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Miami",
      "state": "FL",
      "country": "United States",
      "classification": "Class I",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "73361",
      "recalling_firm": "Super Herbs",
      "address_1": "10740 Sw 222nd Dr",
      "address_2": "N/A",
      "postal_code": "33170-6544",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "9 consignees - only 9 bottles distributed",
      "recall_number": "D-0909-2016",
      "product_description": "SUPER HERBS 350 mg, 30 capsules per bottle.",
      "product_quantity": "9 bottles",
      "reason_for_recall": "Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.",
      "recall_initiation_date": "20151123",
      "center_classification_date": "20160526",
      "termination_date": "20241001",
      "report_date": "20160601",
      "code_info": "All lots"
    }
  ]
}